跳至主要内容
临床试验/NL-OMON53918
NL-OMON53918尚未招募不适用

Investigation on the Cortical Communication (CortiCom) System - CortiCom

niversitair Medisch Centrum Utrecht0 个研究点目标入组 2 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 18-70 years
  • Clinical diagnosis of locked-in state caused by traumatic brain injury,
  • brainstem stroke,
  • neurodegenerative disease, neuromuscular disease or another cause
  • Complete or incomplete tetraplegia (quadriplegia) or tetraparesis
  • (quadriparesis)
  • Motor-related speech impairment (dysarthria or anarthria)
  • Either receiving tracheostomy invasive ventilation, or having a stable and
  • respiratory situation without respiratory support, allowing for safe
  • intubation, mechanical ventilation and detubation during surgery according to
  • the involved clinicians, and, if relevant (e.g., in case of a progressive
  • condition), in combination with a confirmed desire to receive tracheostomy
  • invasive ventilation when that becomes necessary
  • Meeting surgical safety criteria, including surgical clearance by the study
  • Meeting (neuro)psychological evaluation criteria
  • Ability to communicate reliably, such as through eye movement
  • Willingness and ability to provide informed consent
  • Lives within reasonable distance from UMC Utrecht
  • Participant consents to the study and still wishes to participate at the time
  • of the study
  • Vision and hearing largely intact

排除标准

  • Performance on formal neuropsychological testing that indicates a significant
  • recent psychiatric disorder, cognitive or behavioral impairment, that would
  • interfere with obtaining informed consent or fully participating in study
  • Medical conditions contraindicating surgery of a chronically implanted device
  • or that could
  • interfere with study participation (for example active infections, unexplained
  • fever, existing scalp lesions or skin breakdown, osteomyelitis, hepatitis, any
  • autoimmune disease/disorder, epilepsy, skin disorders causing excessive skin
  • sloughing or poor wound healing, cranioplasty, significant cardiovascular,
  • metabolic, or renal impairments, chronic oral or intravenous use of steroids or
  • immunosuppressive therapy, active cancer within the past year or requires
  • chemotherapy, uncontrolled autonomic dysreflexia within the past 3 months,
  • hydrocephalus with or without an implanted ventricular shunt or a medical
  • contraindication to stop anti-coagulant medications during surgery)
  • Presence of pre-surgical findings in anatomical, functional, and/or vascular
  • neuroimaging that makes achieving implant locations too challenging or
  • incompatible with desired risk levels
  • Inability to undergo MRI for pre-implantation evaluation, for example due to
  • the presence
  • of implanted devices that are incompatible with MRI, which may include
  • pacemakers,
  • cardiac defibrillators, spinal cord or vagal nerve stimulators, deep brain
  • stimulators, and
  • cochlear implants
  • Anticipated need for MRI after implantation of the CortiCom assembly

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验